C

Centrillion Technologies

Genomics DNA analysis and sequencing tools

Overview

Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.

Work here?Claim your company

About Centrillion Technologies

Simplify's Rating
Why Centrillion Technologies is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareBiotechnologyHealthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$24.3M

Headquarters

Palo Alto, California

Founded

2009

Get referred to Centrillion Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 site updates show active product marketing and service availability.
  • Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
  • The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.

What critics are saying

  • VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
  • Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
  • Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.

What makes Centrillion Technologies unique

  • Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
  • VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
  • The company still owns a rare integrated stack: chips, assays, and clinical-lab services.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$24.3M

Below

Industry Average

Funded Over

4 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
$45M
$65M
$100M

Growth & Insights

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

4%

Recently Posted Jobs

Sign up to get curated job recommendations

Centrillion Technologies is Hiring for 28 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs